|

MT-401-OTS Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Marker Therapeutics, Inc.1

Indications

  • Acute Myeloid Leukemia, in Relapse1
  • MDS1
  • Cancer1

Duarte, California1 trial

Safety of MT-401-OTS in Patients With Relapsed AML or MDS

City of Hope Center (City of Hope National Medical Center, City of Hope Medical Center)

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.